Recent evolution in proteomics approaches from 2-dimensional gel electrophoresis to peptidebased "shotgun proteomics" methods has greatly enhanced the abilities of scientists to uncover expression changes among "low abundant" proteins. Shotgun proteomics methods typically employ stable isotope labeling techniques to distinguish peptides from the various sources that are compared. Recently, a new shotgun quantitative proteomics technology called isobaric tags for relative and absolute quantification (iTRAQ) has been developed for protein expression analysis. The major strength of the iTRAQ technology is its ability to compare the proteomic changes among multiple samples in a single experiment. Here we present a protocol on using the eight-plex iTRAQ approach for the discovery of molecular targets in oligodendrocyte progenitor cells during rapamycin-induced inhibition of differentiation. We would provide the technical details on peptide labeling, chromatography, mass spectrometry, database search and bioinformatics procedures for the identification of differentially expressed proteins.
Introduction
Systems biological approaches are increasingly used as unbiased discovery tools to gain insights into the functional molecular alterations during neurological diseases (1). Currently microarray analysis has been a method of choice for "system-wide" gene expression analysis; however the application of microarray approaches has limitations in select biological scenerios, e.g., in cerebrospinal fluids which are mostly devoid of mRNAs. Furthermore, mRNA changes do not always correlate directly to changes at either protein levels or activities as the result of varying regulatory steps during translation, post-translational modifications, sub-cellular localization and degradation (2). An evolving approach towards comprehensive understanding of the molecular mechanisms underlying neurological diseases is shotgun neuroproteomics, i.e., the large-scale quantification of peptides and proteins within the contexts of stem cell differentiation, neurodegeneration, neuroregeneration, etc (3, 4). Accurate quantification of peptides relies on the availability of high resolution mass spectrometers that are increasingly robust and are equipped with sophisticated bioinformatic tools for routine high-throughput analysis. As an example of earlier shotgun methods, isotope-coded affinity tags (ICAT) reagents are used to label proteins (5). They are thiol-reactive chemical "tags" that are designed to contain either a light [ 12 C] or heavy [ 13 C] ICAT reagent with a mass difference of 9 Da. Relative protein abundance is determined from the relative MS ion abundance of the corresponding ICAT-labeled peptides. Since the ICAT method selectively quantifies only cysteine-containing peptides, it is able to quantify both protein expression and oxidative modification changes, but unable to quantify proteins that do not contain cysteines (6, 7). Alternatively, in stable isotope labeling by amino acids in cell culture (SILAC) approach (8), the proteomes from two or more cell 5 populations are compared which are metabolically labeled during protein synthesis with either light or heavy stable isotope-incorporated amino acids during cell culture. Quantification of proteins is achieved by comparing the relative abundance of peptides with identical sequences, yet distinguishable in MS by their relative mass due to "heavy" amino acid incorporation.
Although SILAC has been proven effective for large scale quantification of proteins and their phosphorylation changes, it cannot be readily used for studying terminally differentiated cells including neurons since they are not rapidly dividing to incorporate SILAC-specific amino acids into proteins. In addition, this method is not suitable for routine analysis of tissues. By comparison, the iTRAQ approach has been successfully used for multiplexed protein expression analysis from both animal tissues and neuronal cells (9-15). This method utilizes the covalent labeling of peptides with isobaric mass tags for simultaneous identification and quantification of peptides derived from up to eight categories using tandem mass spectrometry (MS/MS) methods.
iTRAQ reagents are identical in mass, therefore isobaric, and are consisted of a variety of isotope-incorporated reporter groups, corresponding stable isotope mass balance groups, and a peptide reactive group. These reagents are covalently linked with peptides via primary amines at lysine side chains and N-termini. The iTRAQ-labeled peptides from up to eight samples can be combined, fractionated using two-dimensional liquid chormatography (LC) and identified and quantified using MS/MS. iTRAQ-labeled peptides labeled with any one of the eight iTRAQ tags are eluted at the same retention time during the LC steps and they display identical mass during 
Two-Dimension LC Separation of Peptides
The combined iTRAQ-labeled peptides are fractionated first with strong cation exchange chromatography and then with reversed phase chromatography.
Strong Cation Exchange Liquid Chromatograpy (SCXLC)
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Various reagents (e.g. TEAB, isopropanol, TCEP, detergents and excess iTRAQ reagents) used during protein extraction, digestion and labeling may interfere with either reversed-phase liquid chromatography steps or MS identification and quantification steps; therefore they must be removed completely beforehand. Peptide mixture is initially fractionated on a PerSeptive
BioCAD SPRINT Perfusion chromatography system equipped with a PolySULFOETHYL A strong cation exchange column.
1. Reconstitute the iTRAQ labeled peptide mixture by adding 4 ml of the SCXLC mobile phase A (see Note 13). Test the pH of the peptide solution using a pH paper.
If necessary, adjust the pH of the solution to between 2.7-3.0 by addition of 1 M phosphoric acid.
2. Centrifuge the sample at 20,000 × g for 15 min at 25 ºC to pellet the precipitates and particulates. Carefully transfer the clarified solution into a fresh tube. format using Probot, which produces a spot every 12.5 sec (see Note 19).
5. Repeat the RPLC steps for each of the SCXLC fractions.
Mass Spectrometry:
Peptides spotted on the MALDI plates are analyzed on a 4800 Plus MALDI TOF/TOF Analyzer using 4000 Series Explorer Software.
1. Tune and optimize the sensitivity and resolution of the mass spectrometer using the mass standard mixture kit. Check and optimize both metastable ion suppressor and the timed-ion-selector for specific precursor ion selection at the maximum resolution of 400, corresponding to ± 2.5 Da at m/z of 1000. Optimal performing instrument is very important for accurate iTRAQ quantification outcome (13). Software. Then create a new spot set using a predefined spot set template. Load the sample MALDI plate into the mass spectrometer using the newly established spot set. laser shots. In the MS/MS processing method, each spectrum is smoothed using the Savitsky-Golay algorithm with points across peak set at 3 and polynomial order set at 4.
8. Set the medium CID gas recharge pressure to medium with a threshold of 5.0 × 10 7 torr.
Bioinformatics
Peptide identification and quantification is determined by ProteinPilot software (v. 4. To estimate the protein false discovery rate (FDR), all spectra are also searched against a decoy IPI Rat database containing all the same proteins with reversed sequences using the same search parameters as described above. The FDR is calculated as
FDR = 2 × (N decoy ) / (N decoy + N forward )
where N decoy is number of proteins identified using the decoy database, N forward is the number of proteins identified using the regular protein database (in this case Rat IPI protein database) (13, 24).
If the FDR is higher than the generally accepted 1.0%, then repeat the search using
higher Unused ProtScore until the FDR reach less than 1.0%. 
Protein Quantification
Alternate Protein Identification and Quantification Procedures
Different database search algorithms identify only a fraction of the large number of spectra generally acquired during a shotgun proteomics experiment. They may also produce different identification and quantification results based on the identification cutoff criteria (25). It has been suggested that by using multiple search engines, a higher proportion of the proteome can be 4. Load the *.dat file generated by Mascot and select the IPI protein database to be used for additional analysis by X! Tandem, using the same search parameters as used for the Mascot search (see Note 25).
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5. After the search is completed, view the list of all the matched proteins in the sample pane of Scaffold. Set the minimum protein identification probability score to 95%, minimum number of peptides to 2 and minimum peptide identification probability score to 95% (see Note 26).
6. Invoke the statistics pane in the Q+ module of Scaffold to evaluate the consistency of expression changes among different peptides belonging to the same protein (Fig. 2) .
If most of the light dots (each representing a peptide) fall near an optimal 45° reporter ion correlation line drawn over the scatter plot of all the peptides identified from a control and rapamycin-treated sample, such observation represents an 1:1 ratio between the selected samples. Therefore, the protein is not differentially expressed. If the selected protein is up-regulated then the light spots representing the peptides within this protein on the scatter plot would have a slope greater than one. If the protein is down-regulated, the expected slope would be less than one (Fig. 2) . 
Notes
1. Removal of residual media is very important. Otherwise, the components in cell culture media may interfere with subsequent digestion and iTRAQ labeling, resulting in external variability in the samples to be analyzed. We use PBS without any ammonium salt to completely wash the cells and to remove remaining media components. Traces of PBS should be removed by using a fine pipette tip, preferably with the gel loading tip without disturbing the cell pellets.
2. The lysis buffer described here has been successfully used to extract both soluble and membrane proteins. Other alternate buffers can also be used. One such buffer contains 20 mM TEAB, 25 mM Na 2 CO 3 and 0.1% (v/v) of protease inhibitor cocktail, pH 8.5. Buffer based on urea can be also used. However, care must be taken to avoid buffers that contain primary amines (e.g. tris) which interfere with subsequent iTRAQ labeling.
3. It is very important to estimate the protein concentration of all the samples accurately.
A protein concentration assay that is fully compatible with the lysis buffer should be employed. Here, we use the detergent-compatible BCA protein assay. For urea containing lysis buffer, the Bradford protein assay should be used.
4.
As per iTRAQ manufacturer instruction, each protein sample should be between 5
and 100 μg for each iTRAQ labeling reaction. To ensure, maximum labeling efficiency, sample volumes should not be more than 50 μl each. If the sample volume is larger than 50 μl, a speed vac or lyophilizer can be used to reduce the sample volume before iTRAQ labeling. To achieve effective reduction of protein disulfides, final concentration of TCEP should be maintained at 4 mM. If urea is used in lysis 25 buffer, samples can be incubated at 37 ºC during the reduction step to avoid any carbamylation of amino acids (30). Final concentration of MMTS should be maintained at 8 mM for effective alkylation of reduced cysteines.
5. For effective trypsin digestion, dilute the sample so that the final concentrations of the detergents and other chaotropic reagents do not inhibit trypsin activity.
6. Check the protein digestion efficiency before proceeding to iTRAQ labeling. Take 12. To remove the TEAB completely, re-suspend the dried sample in 250 μl of HPLC grade water and dry again completely using speed vac. Repeat the process twice.
Dried peptides can be stored at -80 ºC till the next step.
13. After re-suspension of the peptides, make sure that concentration of the buffer salts is 26. Minimum protein identification probability set the threshold requirement for Scaffold to calculate the probability of correct protein identification. Minimum number of peptides set the number of unique peptides that must be found for a given protein in order to consider the protein to be identified. Minimum peptide identification probability set how certain (C. I. %) a peptide identification must be before it can be counted toward the minimum number of peptides. 
